Efficacy and safety of once-monthly pasireotide in Cushing's disease: A 12 month clinical trial

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2017) Efficacy and safety of once-monthly pasireotide in Cushing's disease: A 12 month clinical trial. The Lancet Diabetes and Endocrinology. ISSN 2213-8587

Abstract

Metadata

Authors/Creators:
  • Lacroix, A.
  • Gu, F.
  • Gallardo, W.
  • Pivonello, R.
  • Yu, Y.
  • Witek, P.
  • Boscaro, M.
  • Salvatori, R.
  • Yamada, M.
  • Tauchmanova, L.
  • Roughton, M.
  • Ravichandran, S.
  • Petersenn, S.
  • Biller, B.M.K.
  • Newell-Price, J.
Copyright, Publisher and Additional Information: © 2017 Elsevier. This is an author produced version of a paper subsequently published in Lancet Diabetes and Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Published (online): 12 October 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUSTSTH16153
Depositing User: Symplectic Sheffield
Date Deposited: 03 Nov 2017 11:41
Last Modified: 12 Apr 2018 00:39
Published Version: https://doi.org/10.1016/S2213-8587(17)30326-1
Status: Published online
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/S2213-8587(17)30326-1

Share / Export

Statistics